Tan; Lushi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tan; Lushi.The latest application filed is for "process for making m1 receptor positive allosteric modulators".

Company Profile

1.12.17

Tan; Lushi - Edison NJ
Tan; Lushi - Rahway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for making M1 receptor positive allosteric modulators Grant 10,308,633 - Chen , et al.	2019-06-04
Process For Making M1 Receptor Positive Allosteric Modulators App 20180265493 - Chen; Qinghao ; et al.	2018-09-20
Process for preparing chiral dipeptidyl peptidase-IV inhibitors Grant 10,053,466 - Chung , et al. August 21, 2	2018-08-21
Process For Preparing Chiral Dipeptidyl Peptidase-iv Inhibitors App 20180093992 - Chung; John Y. L. ; et al.	2018-04-05
Process for preparing chiral dipeptidyl peptidase-IV inhibitors Grant 9,862,725 - Chung , et al. January 9, 2	2018-01-09
Processes For The Preparation Of A Bace Inhibitor App 20170233382 - Miller; Steven P. ; et al.	2017-08-17
Process For Preparing Chiral Dipeptidyl Peptidase-iv Inhibitors App 20170158701 - Chung; John Y. L. ; et al.	2017-06-08
Process for preparing chiral dipeptidyl peptidase-IV inhibitors Grant 9,527,855 - Zacuto , et al. December 27, 2	2016-12-27
Process For Preparing Chiral Dipeptidyl Peptidase-iv Inhibitors App 20160024100 - Zacuto; Michael J. ; et al.	2016-01-28
Process for preparing chiral dipeptidyl peptidase-IV inhibitors Grant 9,187,488 - Zacuto , et al. November 17, 2	2015-11-17
Process for the production of a crystalline glucagon receptor antagonist compound Grant 8,232,413 - Cohen , et al. July 31, 2	2012-07-31
Process For Making Glucocorticoid Receptor Ligands App 20100228036 - Chen; Qinghao ; et al.	2010-09-09
Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto Grant 7,786,314 - Hartner , et al. August 31, 2	2010-08-31
Process For The Production Of A Crystalline Glucagon Receptor Antagonist Compound App 20100184995 - Cohen; Benjamin M. ; et al.	2010-07-22
Process for synthesizing a substituted pyrazole Grant 7,709,658 - Tan , et al. May 4, 2	2010-05-04
Process for Synthesizing 2-Phenyl-1H-Phenanthro[9,10-d]Imidazole Derivative App 20090203922 - Belyk; Kevin Michael ; et al.	2009-08-13
4-Oxo-1-3-Substituted Phenyl-1,4-Dihydro-1,8-Napthyridene-3-Carboxamide Phosphodiesterase-4 Inhibitor and a Method of Preparing Same App 20090105479 - Cameron; Mark ; et al.	2009-04-23
Process for synthesizing a substituted pyrazole App 20090054662 - Tan; Lushi ; et al.	2009-02-26
Polymorphs of an androgen receptor modulator Grant 7,365,202 - Tan , et al. April 29, 2	2008-04-29
Process for making fluorinated 4-azasteroid derivatives Grant 7,301,026 - Tan , et al. November 27, 2	2007-11-27
Polymorphs of an androgen receptor modulator App 20070129548 - Tan; Lushi ; et al.	2007-06-07
Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto App 20070112030 - Hartner; Frederick W. ; et al.	2007-05-17
Process for making fluorinated 4-azasteroid derivatives App 20060252937 - Tan; Lushi ; et al.	2006-11-09
Process for preparing integrin antagonist intermediates Grant 6,706,885 - Yasuda , et al. March 16, 2	2004-03-16
Process for preparing integrin antagonist intermediates App 20030004353 - Yasuda, Nobuyoshi ; et al.	2003-01-02
Synthesis of ketosulfone esters App 20020143205 - Chen, Cheng Yi ; et al.	2002-10-03
Process for the synthesis of an endothelin receptor antagonist App 20020107391 - Frey, Lisa F. ; et al.	2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.